Navigation Links
Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
Date:12/30/2008

NEW BRUNSWICK, N.J., Dec. 30 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced the completion of its previously announced acquisition of Omrix Biopharmaceuticals, Inc., a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products. Omrix is expected to operate as a stand-alone entity reporting through ETHICON, Inc., a Johnson & Johnson company.

About Johnson & Johnson

Caring for the world, one person at a time...inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our 119,400 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
2. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
3. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
4. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
5. Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
6. Migenix averts proxy contest; reaches agreement with DJohnson holdings
7. Craig Johnson Joins Ardea Biosciences Board of Directors
8. Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
9. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
10. Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
11. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...lif. Nov. 5, 2009 Complete Genomics, a third-gen...ounced publication of a report in the journal Sci...atform, including analysis of sequence data from t...for these three genomes sequenced on the proof-of-...5 for 87x coverage to $1,726 for 45x coverage for ...
(Date:11/6/2009)...6 Myriant Technologies LLC ("Myria...facturer of renewable bio-chemicals, Uhde Corpora...der Uhde GmbH, one of the world,s leading engineer...iance for the engineering, procurement & const...plants based on renewable feedstocks. The executi...
(Date:11/6/2009).... 6 Intarcia Therapeutics, Inc. de...UROS® continuous delivery of exenatide) progr...th Annual Diabetes Technology Meeting in San Franc...-bin/prnh/20050301/SFTU126LOGO ) ,, Continuou...Lowers Plasma Glucose, HbA1c and Reduces Weight in...
(Date:11/5/2009)...v. 5 DSM Pharmaceutical Products t...liance with Galenix, Saint Jean D,Illac, France, w...nufacturing partner for Galenix commercial product...llaborate on business development opportunities co...ed on the strength of Galenix in drug product deve...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
... Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotechn...nds for the treatment of cardiovascular disease, w...nvestments reconstitutes its family of,U.S. indexe...eliminary list,of additions posted on http://www....ed for inclusion in this objective,market-driven i...
... of 1918 killed between 30 and 50 million people. ...ath was acute respiratory distress syndrome (ARDS)...e body during which the lung becomes severely dama...viral infections, but also by chemical agents. The...c acid when aspirated. Once ARDS has developed, su...
...nternationally funded training programmes in biote...eveloping countries are unprepared to effectively ...es, leaving the world community open to serious bi...tions University Institute of Advanced Studies, sa...untries of Africa, Central Asia, Oceania and the C...
Other Biology Technology:VIA Pharmaceuticals Set to Join Russell Microcap Index 2VIA Pharmaceuticals Set to Join Russell Microcap Index 3VIA Pharmaceuticals Set to Join Russell Microcap Index 4New strategies against bird flu 2Most developing countries ill-equipped to ensure global biosafety: UN University 2Most developing countries ill-equipped to ensure global biosafety: UN University 3
(Date:11/4/2009)...,, REDWOOD CITY, Calif., Oct. 20 /PRNewswire/ -...entity and authentication solutions, today announc...int-of-sale (POS) software for quick-service resta...nto their NextGen POS and Classic POS solutions. W...int biometrics to boost cashier accountability and...
(Date:11/4/2009)...,, WALL, N.J., Oct. 26 /PRNewswire-FirstCall/ -... BKYI), a leader in finger-based biometric identif...dentity solutions at the AABB TXPO conference bein...ctober 25-27 2009. BIO-key will provide hands-on p...tification technology in booth #424. Also, at 5 PM...
(Date:11/4/2009)...,, SEATTLE, Nov. 4 Glencoe Soft...opy Environment (OME) Consortium ( http://openmic...tion with the American Society of Cell Biology,s e...rary." The ASCB has been awarded a $2.5M stimulus ...(NIH) Grand Opportunities program, as part of the ...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Fighting the burden of mental disorders 9897 1Fighting the burden of mental disorders 9897 2Need for Pain and Palliative Care Mentorship Addressed at PAINweek 2009 56978 1Need for Pain and Palliative Care Mentorship Addressed at PAINweek 2009 56978 2New sources of biofuel to take pressure off traditional crops 9893 1
...ersity of Illinois have constructed the first glob...Their approach offers a new window on the evolutio...is week in the online edition of the Proceedings o...k relies on established techniques of phylogenetic... evolution of genes and organisms but which have n...
...the Great Lakes and neighboring waterways is appro...ser, Cornell professor of aquatic animal medicine ...emorrhagic septicemia virus (VHSV), which causes a...ified in 19 species and poses a potential threat t..., "It’s pretty obvious this is an epidemic even if...
...mple HIV and bird flu able to make the cells withi...Researchers at the University of Copenhagen shed n...laboration between molecular biologists and physic...how the cell functions and of the interplay betwee...ve the expertise and the technique to be able to m...
Other Biology News:Study of protein folds offers insight into metabolic evolution 2Study of protein folds offers insight into metabolic evolution 3Cornell lab confirms deadly fish virus spreading to new species 2Danish researches solve virus puzzle 2
Bar code reader kit - for centrifuge from Thermo Scientific
CQCS kit for etra KR 4i from Thermo Scientific
...RIOMAG Magnetic Stirrers operate without any movin...ngs, making VARIOMAG Magnetic Stirrers 100% wear-f...G inductive drive can be hermetically sealed, maki...s. This is why VARIOMAG Magnetic Stirrers are part...
Fluoroskan Ascent FL, 100-240 V, one dispenser from Thermo Scientific
Biology Products: